{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T07:41:16Z","timestamp":1788853276289,"version":"build-2803163510"},"reference-count":0,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Oncol"],"published-print":{"date-parts":[[2010,6,23]]},"DOI":"10.3892\/ijo_00000688","type":"journal-article","created":{"date-parts":[[2010,6,23]],"date-time":"2010-06-23T12:28:24Z","timestamp":1277296104000},"source":"Crossref","is-referenced-by-count":7,"title":["ER-60 (PDIA3) is highly expressed in a newly established serous ovarian cancer cell line, YDOV-139"],"prefix":"10.3892","volume":"37","author":[{"family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","container-title":["International Journal of Oncology"],"original-title":[],"link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijo_00000688\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,4,27]],"date-time":"2017-04-27T09:39:31Z","timestamp":1493285971000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/ijo\/37\/2\/399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,23]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,6,23]]}},"URL":"https:\/\/doi.org\/10.3892\/ijo_00000688","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,23]]}}}